Isolation of Salmonella enterica Serotype Isangi from a Suspected Case of Enteric Encephalopathy

• Published in: Indian journal of medical microbiology Vol. 27; no. 1; pp. 65 - 66
• Main Authors: Kulkarni, R.D, Ajantha, G.S, Shubhada, C, Jain, P
• Format: Journal Article
• Language: English
• Published: India Medknow Publications on behalf of Indian Association of Medical Microbiology 01.01.2009; Elsevier B.V; Elsevier Limited
• Subjects: Acids; Adult; Anti-Bacterial Agents - therapeutic use; Bacteremia - diagnosis; Bacteremia - drug therapy; Bacteremia - microbiology; Bacteria; beta-Lactamases - biosynthesis; Ceftriaxone - therapeutic use; Fever; Humans; India; Male; Neurotoxicity Syndromes - diagnosis; Neurotoxicity Syndromes - drug therapy; Neurotoxicity Syndromes - microbiology; Non salmonella; Salmonella; Salmonella enterica; Salmonella enterica - drug effects; Salmonella enterica - isolation & purification; Salmonella Infections - complications; Salmonella Infections - diagnosis; Salmonella Infections - drug therapy; Salmonella Infections - microbiology; Salmonella Isangi; India; Salmonella Isangi; Non salmonella; salmonella
• ISSN: 0255-0857; 1998-3646
• DOI: 10.1016/S0255-0857(21)01759-X

Nontyphoidal salmonella species are thought to be potentially infectious to humans and many are documented to cause human diseases. We isolated S. Isangi from the blood of a 30-year-old man with complaints of diarrhoea, fever, and altered sensorium. The serotype of the isolate was confirmed at National Salmonella Centre (Vet.), Division of Bacteriology and Mycology, Indian Veterinary Research Institute, Izzatnagar, India. The isolate was not an extended spectrum beta-lactamase (ESBL) producer and the patient responded well to ceftriaxone. We reviewed the literature concerning infections caused by salmonella; however, did not find any report related to S. Isangi infection in human beings from India.